Filter
1018
Text search:
hospital
readiness
Featured
Recommendations
121
New Publications
267
Language
Document type
No document type
506
Guidelines
185
Studies & Reports
157
Manuals
67
Strategic & Response Plan
60
Fact sheets
15
Situation Updates
14
Training Material
9
Resource Platforms
4
Online Courses
1
Countries / Regions
India
54
Kenya
40
Sierra Leone
35
Tanzania
33
Ethiopia
31
Global
30
Nigeria
22
Syria
22
Liberia
20
Nepal
20
Malawi
20
Ghana
19
South Africa
18
Bangladesh
18
Rwanda
17
Uganda
16
Zambia
16
Russia
16
Congo, Democratic Republic of
15
Mozambique
14
Brazil
14
Myanmar / Burma
14
Western and Central Europe
14
Ukraine
12
Philippines
11
Latin America and the Carribbean
11
Namibia
10
West and Central Africa
10
Senegal
9
East and Southern Africa
9
Africa
9
Zimbabwe
7
Indonesia
7
Angola
7
Middle East and North Africa
7
South–East Asia Region
7
Guinea-Bissau
5
Cameroon
5
Haiti
5
Eswatini/ Swaziland
5
Madagascar
5
Eastern Europe
5
Guinea
4
South Sudan
4
Cambodia
4
Central African Republic
4
Eastern Europe and Central Asia
4
USA
3
Pakistan
3
Ecuador
3
Botswana
3
Lesotho
3
Yemen
3
Asia
3
Burkina Faso
2
Mali
2
Jordan
2
Lebanon
2
Thailand
2
China
2
Benin
2
Western Pacific Region
2
Moldova
2
Vietnam
2
Mauritius
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Somalia
1
Afghanistan
1
Turkey
1
Egypt
1
Gambia
1
Malaysia
1
Mauritania
1
Singapore
1
Sudan
1
Burundi
1
El Salvador
1
Libya
1
Sri Lanka
1
Bhutan
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Gabon
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
488
Clinical Guidelines
68
Public Health
56
Women & Child Health
54
Key Resources
40
Capacity Building
30
Pharmacy & Technologies
9
Toolboxes
COVID-19
209
Rapid Response
58
HIV
52
Mental Health
44
Ebola
39
AMR
37
TB
29
Caregiver
29
Conflict
27
Planetary Health
12
NCDs
11
Natural Hazards
10
Disability
8
Global Health Education
8
Refugee
6
Pharmacy
5
Cholera
4
Social Ethics
4
NTDs
4
Zika
3
Specific Hazards
3
Health Financing Toolbox
3
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that
...
Our spiritual health profoundly impacts our physical health, well-being, and quality of life. Just as medical professionals care for our bodies and minds, spiritual care practitioners care for our spirits. The increasing need for spiritual care makes these practitioners even more crucial. However, m
...
Severe acute respiratory infections treatment centre: practical manual to set up and manage a SARI treatment centre and a SARI screening facility in health care facilities
This guidance is targeted to primary health care policy-makers and only addresses issues relevant for primary health care providers. It has been prepared on the basis of a systematic review of the best available evidence and emergent country practices in response to the COVID-19 outbreak in the WHO
...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Experiences and recommendations from the International Red Cross and Red Crescent Movement.
Measures imposed by governments to prevent the spread of the disease, including lockdown restrictions, quarantines, physical distancing, and their economic and social consequences, further increase this dist
...
A Organização Mundial da Saúde (OMS) convida seus Estados Membros, serviços de saúde e outras entidades para contribuírem com a OMS na vigilância de dados clínicos de casos de pacientes hospitalizados com COVID-19, a fim de melhorar o entendimento global sobre a apresentação clínica dessa
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug
...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the
...
This study has two broad objectives. Thefirst objective was to assess the financialsustainability of CBHI schemes, focusing on schemes that have been operational for more than twoyears. The first componentprovidesquantitative descriptions of enrollment, utilization, and financial solvency of CBHI sc
...
Explainer for countries based on commonly asked questions
12 November 2020
This document aims to explain how COVAX vaccines will be allocated amongst participants.
This checklist helps to identify the necessary measures to be implemented to mitigate infection transmission among travellers and ground-crossing staff in the context of the COVID-19 pandemic. It features key questions and considerations for gauging the capacity of responding to COVID-19 transmissio
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global
...
Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition: web annex A: protocol for evaluating minimum package of care of morbidity management and disability prevention for lymphoedema management in designated health facilit
...
